Streetbeat News

Earnings

AVTX

KOD

PMEC

Kodiak Sciences Inc. shares fell by around 20% after reporting a wider-than-expected Q4 loss. Other stocks showed significant movement, with Avalo Therapeutics leading gainers with a 430% jump after acquiring a Phase 2-ready anti-IL-1β mAb and announcing a private placement financing. Losers included Primech Holdings, falling 46.7% after issuing financial updates. The market saw a mix of positive and negative movements across various sectors.

Portfolio Pulse from Avi Kapoor

March 28, 2024 | 6:08 pm

TBLA

Analysts have mixed views on Taboola.com (NASDAQ:TBLA), with ratings ranging from bullish to bearish over the last quarter. The average 12-month price target has been raised to $5.75, up from $5.25. Key analysts from Needham and Oppenheimer have maintained or raised their ratings, with price targets reaching up to $6.00. Taboola.com, a tech company specializing in AI-based recommendations, shows strong financial performance with a notable revenue growth rate of 13.07%, a net margin of 0.89%, and an ROE of 0.35%.

Portfolio Pulse from Benzinga Insights

March 28, 2024 | 6:01 pm

AEM

GOLD

IWM

NEM

NKLA

U.S. equity indices were steady as traders reassessed interest rate cut expectations following comments from Fed Governor Christopher J. Waller. The U.S. GDP for Q4 was revised up to 3.4%, and gold reached new highs at $2,225 per ounce. Bitcoin rebounded beyond $70,700. The iShares Russell 2000 ETF outperformed large-cap indices. Stocks like Newmont Corp., Barrick Gold Corp., and Agnico Eagle Mines rallied with gold prices. Nikola Corp. surged on short squeeze rumors, and Estée Lauder rose after announcing a distribution deal with Amazon.

Portfolio Pulse from Piero Cingari

March 28, 2024 | 5:49 pm

WBA

Walgreens Boots Alliance shares are trading higher due to volatility following the company's Q2 earnings report.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 5:37 pm

CHT

Chunghwa Telecom Inc. (NYSE:CHT) experienced a slight drop in share price by 0.43% to $39.16 in the current market session. Despite a 3.18% increase over the past month, the stock has seen a minor decrease of 0.28% over the past year. The company's P/E ratio of 26.35, compared to the industry average of 54.22, suggests it may be undervalued or expected to perform worse than its peers in the Diversified Telecommunication Services industry.

Portfolio Pulse from Benzinga Insights

March 28, 2024 | 5:30 pm

CCL

CUK

Carnival Corporation's shares are trading lower following the company's recent report of its Q1 earnings.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 5:29 pm

AMZN

WBA

Walgreens Boots Alliance (WBA) reported fiscal Q2 earnings that exceeded estimates but lowered its full-year earnings guidance due to a challenging macroeconomy. The company is undergoing a healthcare transformation, highlighted by a 33% sales increase in its U.S. healthcare division, driven by acquisitions and business growth. However, a nearly $6 billion charge related to the decline in value of its investment in VillageMD resulted in a steep net loss. Despite this, Walgreens is continuing its transformation efforts, including cost-cutting measures to save $1 billion by fiscal 2024. Amazon.com Inc (AMZN) is also expanding into the healthcare market, increasing competition for Walgreens.

Portfolio Pulse from Upwallstreet

March 28, 2024 | 5:24 pm

KVLE

MSM

UDI

MSC Industrial Direct Co., Inc. (NYSE:MSM) reported a decline in Q2 FY24 net sales by 2.7% Y/Y to $935.3 million, missing consensus estimates. Adjusted operating income and EPS also fell, with a cautious outlook for FY24. The company completed an acquisition of IP assets from SMRT and offers exposure through UDI and KVLE ETFs.

Portfolio Pulse from Lekha Gupta

March 28, 2024 | 5:09 pm

BOC

Boston Omaha's shares are trading lower following the announcement of their fiscal year 2023 financial results.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 5:08 pm

MDB

In the latest quarter, 26 analysts provided mixed ratings for MongoDB (NASDAQ:MDB), with a shift towards more bullish perspectives compared to previous months. The average 12-month price target is now $447.46, down from $467.37, reflecting a 4.26% decrease. Analyst actions include a range of adjustments to ratings and price targets, indicating varied expectations for MongoDB's future performance. MongoDB's financial performance shows strong growth and profitability, with a notable revenue growth rate of 26.76% and a market capitalization above the industry average.

Portfolio Pulse from Benzinga Insights

March 28, 2024 | 5:01 pm